Novelion ' s Aegerion Resolves U.S. Drug Probes for $40 Million Novelion ' s Aegerion Resolves U.S. Drug Probes for $40 Million

Aegerion Pharmaceuticals Inc will plead guilty to two misdemeanors and pay $40.1 million to resolve investigations into its marketing and sales of an expensive cholesterol drug, U.S. authorities said on Friday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Internal Medicine News Source Type: news